FDA

Stratasys is helping nasal swabs and COVID-19 testing

Posted on Updated on

According to Aaron Pearson, he is Vice President of Public Relations at Stratasys 3D Printing, “The need for widespread COVID-19 testing of millions of people has surfaced another shortage, nasal swabs. Stratasys has added to its efforts to fight the pandemic and ongoing testing requirements by marketing and promoting Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S. The Origin 3D-printed nasopharyngeal swab has been tested in a clinical trial and is considered an FDA Class I Exempt Device.”

 

Nasal swabs and COVID-19 testing: the next step in the Stratasys pandemic response.

3D printed parts during the COVID-19 pandemic

Posted on Updated on

According to the FDA,” Health care providers should-Check the 3D-printed mask‘s seal for leaks, Confirm that they can breathe through any makeshift filter materials, Exercise caution in surgical environments where the need for liquid barrier protection and flammability is a concern. Recognize that the mask may not provide air filtration enough to prevent transmission of infectious agents.
Safely dispose of infectious materials and disinfect any part they intend to reuse.”

Accessories, Components, and Parts During the COVID-19 Pandemic